Perrigo Extended-Release Acetaminophen Launch Delayed By QC Issues
This article was originally published in The Tan Sheet
Executive Summary
Perrigo has postponed its plans to market private label extended-release acetaminophen until it can resolve quality control issues outlined in a recent FDA warning letter.